Cannabinoids have strong antitumor capabilities according to a new study being published in the upcoming issue of the journal Histology and Histopathology, and e-published ahead of print by the National Institute of Health.
“Cannabinoids are a class of chemical compounds with a wide spectrum of pharmacological effects, mediated by two specific plasma membrane receptors (CB1 and CB2)”, says researchers. “Recently, CB1 and CB2 expression levels have been detected in human tumors, including those of brain.”
According to the study; “Cannabinoids-endocannabinoids exert anti-inflammatory, anti-proliferative, anti-invasive, anti-metastatic and pro-apoptotic effects in different cancer types, both in vitro and in vivo in animal models, after local or systemic administration.”
For the study, researchers present “the available experimental and clinical data, to date, regarding the antitumor action of cannabinoids on the tumorigenesis of gliomas.”
The study, conducted by researchers at the University of Athens, can be found by clicking here.